Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group

Haematol Blood Transfus. 1990:33:261-6. doi: 10.1007/978-3-642-74643-7_47.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Germany, West
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myelomonocytic, Acute / drug therapy*
  • Middle Aged
  • Multicenter Studies as Topic
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Thioguanine / administration & dosage

Substances

  • Cytarabine
  • Cyclophosphamide
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1
  • MI-MIV maintenance protocol